Nisa Investment Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Sell |
1,217
-199
| -14% | -$2.78K | ﹤0.01% | 2019 |
|
|
2025
Q1 | $19.3K | Sell |
1,416
-65,205
| -98% | -$886K | ﹤0.01% | 1896 |
|
|
2024
Q4 | $1.36M | Buy |
66,621
+139
| +0.2% | +$2.83K | 0.01% | 795 |
|
|
2024
Q3 | $1.94M | Buy |
66,482
+160
| +0.2% | +$4.66K | 0.01% | 686 |
|
|
2024
Q2 | $1.54M | Buy |
66,322
+193
| +0.3% | +$4.48K | 0.01% | 766 |
|
|
2024
Q1 | $1.36M | Buy |
66,129
+70
| +0.1% | +$1.44K | 0.01% | 785 |
|
|
2023
Q4 | $1.42M | Buy |
66,059
+48,099
| +268% | +$1.03M | 0.01% | 755 |
|
|
2023
Q3 | $371K | Buy |
17,960
+10
| +0.1% | +$206 | ﹤0.01% | 1158 |
|
|
2023
Q2 | $530K | Buy |
17,950
+192
| +1% | +$5.67K | ﹤0.01% | 1060 |
|
|
2023
Q1 | $409K | Sell |
17,758
-160
| -0.9% | -$3.69K | ﹤0.01% | 1122 |
|
|
2022
Q4 | $498K | Hold |
17,918
| – | – | ﹤0.01% | 1118 |
|
|
2022
Q3 | $544K | Buy |
17,918
+102
| +0.6% | +$3.1K | ﹤0.01% | 998 |
|
|
2022
Q2 | $524K | Buy |
17,816
+15,200
| +581% | +$447K | ﹤0.01% | 1038 |
|
|
2022
Q1 | $84K | Sell |
2,616
-1,235
| -32% | -$39.7K | ﹤0.01% | 1682 |
|
|
2021
Q4 | $132K | Sell |
3,851
-2,295
| -37% | -$78.7K | ﹤0.01% | 1412 |
|
|
2021
Q3 | $310 | Sell |
6,146
-48
| -0.8% | -$2 | ﹤0.01% | 1264 |
|
|
2021
Q2 | $486 | Sell |
6,194
-100
| -2% | -$8 | ﹤0.01% | 1146 |
|
|
2021
Q1 | $359 | Buy |
6,294
+450
| +8% | +$26 | ﹤0.01% | 1268 |
|
|
2020
Q4 | $489K | Buy |
5,844
+3,254
| +126% | +$272K | ﹤0.01% | 1161 |
|
|
2020
Q3 | $93K | Buy |
2,590
+1,830
| +241% | +$65.7K | ﹤0.01% | 1566 |
|
|
2020
Q2 | $18K | Buy |
760
+300
| +65% | +$7.11K | ﹤0.01% | 1796 |
|
|
2020
Q1 | $8K | Buy |
+460
| New | +$8K | ﹤0.01% | 1885 |
|